Thrombotic Complications in Paroxysmal Nocturnal Haemoglobinuria: a Literature Review

Overview

Journal Blood Transfus

Specialty Hematology

Date 2012 Jul 14

PMID 22790262

Citations 15

Authors

Alessandra Malato

Giorgia Saccullo

Lucio Lo Coco

Salvatrice Mancuso

Marco Santoro

Samuela Martino

Valentina Zammit

Delia Sprini

Sergio Siragusa

Affiliations

Soon will be listed here.

Citing Articles

Thrombosis in Paroxysmal Nocturnal Hemoglobinuria (PNH): From Pathogenesis to Treatment.

Kokoris S, Polyviou A, Evangelidis P, Grouzi E, Valsami S, Tragiannidis K Int J Mol Sci. 2024; 25(22).

PMID: 39596172 PMC: 11594924. DOI: 10.3390/ijms252212104.

Dingli D, Rizio A, Broderick L, LaGasse K, Rucker S, Carty M Ann Hematol. 2024; 103(12):5213-5227.

PMID: 39551895 PMC: 11695468. DOI: 10.1007/s00277-024-06088-x.

Thromboembolic events in patients with paroxysmal nocturnal hemoglobinuria (PNH): Real world data of a Greek nationwide multicenter retrospective study.

Chatzileontiadou S, Hatjiharissi E, Angelopoulou M, Asimakopoulos J, Loutsidi N, Chatzikonstantinou T Front Oncol. 2023; 13:1128994.

PMID: 36959785 PMC: 10028290. DOI: 10.3389/fonc.2023.1128994.

A review of venous thromboembolism risk assessment models for different patient populations: What we know and don't!.

Mehta Y, Bhave A Medicine (Baltimore). 2023; 102(2):e32398.

PMID: 36637948 PMC: 9839272. DOI: 10.1097/MD.0000000000032398.

Paroxysmal nocturnal haemoglobinuria, diagnosis and haematological findings, first report from Iran, model for developing countries.

Jahangirpour M, Vahedi A, Baghdadi H, Madani T, Behvarmanesh A, Alidadi M EJHaem. 2022; 3(2):335-340.

PMID: 35846057 PMC: 9176096. DOI: 10.1002/jha2.410.

References

Carothers D, Hazra S, Andreson S, Medof M . Synthesis of aberrant decay-accelerating factor proteins by affected paroxysmal nocturnal hemoglobinuria leukocytes. J Clin Invest. 1990; 85(1):47-54. PMC: 296385. DOI: 10.1172/JCI114432. View

Hugel B, Socie G, Vu T, Toti F, Gluckman E, Freyssinet J . Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobinuria and aplastic anemia. Blood. 1999; 93(10):3451-6. View

Miyata T, Takeda J, Iida Y, Yamada N, Inoue N, Takahashi M . The cloning of PIG-A, a component in the early step of GPI-anchor biosynthesis. Science. 1993; 259(5099):1318-20. DOI: 10.1126/science.7680492. View

Rother R, Bell L, Hillmen P, Gladwin M . The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA. 2005; 293(13):1653-62. DOI: 10.1001/jama.293.13.1653. View

Nishimura J, Kanakura Y, Ware R, Shichishima T, Nakakuma H, Ninomiya H . Clinical course and flow cytometric analysis of paroxysmal nocturnal hemoglobinuria in the United States and Japan. Medicine (Baltimore). 2004; 83(3):193-207. DOI: 10.1097/01.md.0000126763.68170.46. View

Ploug M, Plesner T, Ronne E, Ellis V, Hoyer-Hansen G, Hansen N . The receptor for urokinase-type plasminogen activator is deficient on peripheral blood leukocytes in patients with paroxysmal nocturnal hemoglobinuria. Blood. 1992; 79(6):1447-55. View

Araten D, Thaler H, Luzzatto L . High incidence of thrombosis in African-American and Latin-American patients with Paroxysmal Nocturnal Haemoglobinuria. Thromb Haemost. 2005; 93(1):88-91. DOI: 10.1160/TH04-06-0391. View

Socie G, Mary J, de Gramont A, Rio B, Leporrier M, Rose C . Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. French Society of Haematology. Lancet. 1996; 348(9027):573-7. DOI: 10.1016/s0140-6736(95)12360-1. View

McMullin M, Hillmen P, Jackson J, Ganly P, Luzzatto L . Tissue plasminogen activator for hepatic vein thrombosis in paroxysmal nocturnal haemoglobinuria. J Intern Med. 1994; 235(1):85-9. DOI: 10.1111/j.1365-2796.1994.tb01037.x. View

10.

Ziakas P, Poulou L, Rokas G, Bartzoudis D, Voulgarelis M . Thrombosis in paroxysmal nocturnal hemoglobinuria: sites, risks, outcome. An overview. J Thromb Haemost. 2007; 5(3):642-5. DOI: 10.1111/j.1538-7836.2007.02379.x. View

11.

Kruatrachue M, Wasi P, Na-Nakorn S . Paroxysmal nocturnal haemoglobinuria in Thailand with special reference to as association with aplastic anaemia. Br J Haematol. 1978; 39(2):267-76. DOI: 10.1111/j.1365-2141.1978.tb01097.x. View

12.

Parker C, Omine M, Richards S, Nishimura J, Bessler M, Ware R . Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood. 2005; 106(12):3699-709. PMC: 1895106. DOI: 10.1182/blood-2005-04-1717. View

13.

Sugimori C, Chuhjo T, Feng X, Yamazaki H, Takami A, Teramura M . Minor population of CD55-CD59- blood cells predicts response to immunosuppressive therapy and prognosis in patients with aplastic anemia. Blood. 2005; 107(4):1308-14. DOI: 10.1182/blood-2005-06-2485. View

14.

Dragoni F, Iori A, Pignoloni P, Minotti C, Chiarotti F, Mazzucconi M . Thrombophilic screening in patients with paroxysmal nocturnal haemoglobinuria: a pilot study. Br J Haematol. 2010; 150(4):492-4. DOI: 10.1111/j.1365-2141.2010.08230.x. View

15.

Parker C . Historical aspects of paroxysmal nocturnal haemoglobinuria: 'defining the disease'. Br J Haematol. 2002; 117(1):3-22. DOI: 10.1046/j.1365-2141.2002.03374.x. View

16.

Dusse L, Cooper A, Lwaleed B . Tissue factor and nitric oxide: a controversial relationship!. J Thromb Thrombolysis. 2007; 23(2):129-33. DOI: 10.1007/s11239-006-0001-9. View

17.

Araten D, Notaro R, Thaler H, Kernan N, Boulad F, Castro-Malaspina H . Thrombolytic therapy is effective in paroxysmal nocturnal hemoglobinuria: a series of nine patients and a review of the literature. Haematologica. 2011; 97(3):344-52. PMC: 3291587. DOI: 10.3324/haematol.2011.049767. View

18.

Weitz I . Thrombosis in Paroxysmal Nocturnal Hemoglobinuria - insights into the role of complement in thrombosis. Thromb Res. 2010; 125 Suppl 2:S106-7. DOI: 10.1016/S0049-3848(10)70026-8. View

19.

Hillmen P, Muus P, Duhrsen U, Risitano A, Schubert J, Luzzatto L . Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria. Blood. 2007; 110(12):4123-8. DOI: 10.1182/blood-2007-06-095646. View

20.

Darnige L, Peffault de Latour R, Zemori L, Socie G, Fischer A, Helley D . Antiphospholipid antibodies in patients with paroxysmal nocturnal haemoglobinuria receiving eculizumab. Br J Haematol. 2011; 153(6):789-91. DOI: 10.1111/j.1365-2141.2011.08665.x. View